Anti-COVID-19 Potential of Withaferin-A and Caffeic Acid Phenethyl Ester

Kumar, Vipul and Sari, Anissa Nofita and Gupta, Dharmender and Ishida, Yoshiyuki and Terao, Keiji and Kaul, Sunil C. and Vrati, Sudhanshu and Sundar, Durai and Wadhwa, Renu (2024) Anti-COVID-19 Potential of Withaferin-A and Caffeic Acid Phenethyl Ester. Current Topics in Medicinal Chemistry, 24 (9). pp. 830-842. ISSN 15680266

Full text not available from this repository. (Request a copy)

Abstract

Background:
The recent COVID-19 (coronavirus disease 2019) pandemic triggered research on the development of new vaccines/drugs, repurposing of clinically approved drugs, and assessment of natural anti-COVID-19 compounds. Based on the gender difference in the severity of the disease, such as a higher number of men hospitalized and in intense care units, variations in sex hormones have been predicted to play a role in disease susceptibility. Cell surface receptors (Angiotensin-Converting Enzyme 2; ACE2 and a connected transmembrane protease serine 2- TMPSS2) are upregulated by androgens. Conversely, androgen antagonists have also been shown to lower ACE2 levels, implying their usefulness in COVID-19 management.

Objective:
In this study, we performed computational and cell-based assays to investigate the anti- COVID-19 potential of Withaferin-A and Caffeic acid phenethyl ester, natural compounds from Withania somnifera and honeybee propolis, respectively

Methods:
Structure-based computational approach was adopted to predict binding stability, interactions, and dynamics of the two test compounds to three target proteins (androgen receptor, ACE2, and TMPRSS2). Further, in vitro, cell-based experimental approaches were used to investigate the effect of compounds on target protein expression and SARS-CoV-2 replication.

Results:
Computation and experimental analyses revealed that (i) CAPE, but not Wi-A, can act as androgen antagonist and hence inhibit the transcriptional activation function of androgen receptor, (ii) while both Wi-A and CAPE could interact with ACE2 and TMPRSS2, Wi-A showed higher binding affinity, and (iii) combination of Wi-A and CAPE (Wi-ACAPE) caused strong downregulation of ACE2 and TMPRSS2 expression and inhibition of virus infection.

Conclusion:
Wi-A and CAPE possess multimodal anti-COVID-19 potential, and their combination (Wi-ACAPE) is expected to provide better activity and hence warrant further attention in the laboratory and clinic.

Item Type: Article
Uncontrolled Keywords: Withaferin-A, Caffeic acid phenethyl ester, SARS-CoV-2, Androgen Receptor (AR), Transmembrane Protease Serine 2 (TMPRSS2), Angiotensin Converting Enzyme 2 (ACE2).
Subjects: Medicine & Biology
Depositing User: Maria Regina Karunia
Date Deposited: 09 Jun 2026 03:30
Last Modified: 09 Jun 2026 03:30
URI: https://karya.brin.go.id/id/eprint/58646

Actions (login required)

View Item
View Item